Following the company’s strong earnings report, Needham & Company reiterated a Buy rating on Gilead Sciences (NASDAQ: GILD) and raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE